Table 4.
Exon | Nucleotide Change | Protein Change | Domain | Evolutionary Conservation | Predicted Functional Effect |
---|---|---|---|---|---|
Intron 3–5 | IVS3_IVS5 del27kb† | Transcription initiation site removed | N/A | N/A | Exons 4 and 5 deleted |
7 | c. 100C>T | p.R34X | IC | Non-conserved | Truncated protein; Occurs at glutamic-acid rich N-terminus region; cAMP-and cGMP-dependent protein kinase phosphorylation site |
8 | c.295delA | Frameshift | N/A | N/A | Truncated protein |
13 | c.884 +1G>A‡ | Splice donor | N/A | N/A | Exon 13 skipped |
15 | c. 1165C>T | p.R389X | EC | Non-conserved | Truncated protein |
17 | c. 1534C>T | p.R512X | IC | Non-conserved | Truncated protein |
19 | c. 1714G>A§ | p.D572N | IC | Non-conserved | Benign; Casein kinase II phosphorylation site |
20 | c. 1960A>G | p.M654V | TM5 | Non-conserved | Benign |
TMC1 sequence changes were reported by Kurima et al. (2002) except for p.R389X at exon 15 (Meyer et al., 2005). Membrane-spanning domains, evolutionary conservation and functional effect were determined as described in Table 2.
Because the article did not specify the exact position at which this deletion occurred, it was not possible to rename this sequence variant according to the current nomenclature recommendations.
The traditional nomenclature for c.884 +1G>A was IVS13 +1G>A.
c.1714G>A (p.D572N) was observed in a North American family with dominant hearing impairment.